Corbus Pharmaceuticals Holdings Inc expected to post a loss of $2.06 a share - Earnings Preview

Corbus Pharmaceuticals Holdings

03/11/2023 15:00

* Corbus Pharmaceuticals Holdings Inc  CRBP.OQ   CRBP.O  is
expected to show no change in quarterly revenue when it reports 
results 
    * 
    * ​Refinitiv's mean analyst estimate for Corbus
Pharmaceuticals
Holdings Inc is for a loss of $2.06 per share. 
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Corbus
Pharmaceuticals Holdings Inc is $71​, above​ its last closing
price of $4.87. ​​​

This summary was machine generated November 3 at 15:00 GMT.  All
figures in US dollars  unless otherwise stated